Paper2847643
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
Abele G and 3 others. Antimicrob Agents Chemother, 1988. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate. Papers, record 2847643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2847643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyclovir | Major topic |
| Antiviral Agents | Major topic |
| Herpesvirus 3, Human | Major topic |
| Nucleic Acid Synthesis Inhibitors | Major topic |
| Animals | |
| Cells, Cultured | |
| Chromatography | |
| DNA Polymerase II | |
| DNA-Directed DNA Polymerase | |
| Fibroblasts | |
| Guanosine Triphosphate | |
| Humans | |
| Kinetics | |
| Vero Cells |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 185190 | Severe chickenpox and purpura fulminans in zoster treated with vidarabine. | J Antimicrob Chemother | 1976 | https://conductscience.org/library/papers/185190 | PubMed |
| 2 | 14166109 | MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY. | Virology | 1964 | https://conductscience.org/library/papers/14166109 | PubMed |
| 3 | 207886 | Purification and characterization of varicella-zoster virus-induced DNA polymerase. | J Virol | 1978 | https://conductscience.org/library/papers/207886 | PubMed |
| 4 | 4925077 | Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. | Br Med J | 1970 | https://conductscience.org/library/papers/4925077 | PubMed |
| 5 | 5166448 | DNA-dependent DNA polymerases from HeLa cell nuclei. II. Template and substrate utilization. | Biochem Biophys Res Commun | 1971 | https://conductscience.org/library/papers/5166448 | PubMed |
| 6 | 177418 | Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus type I and type II. II. Purification and characterization. | J Biol Chem | 1976 | https://conductscience.org/library/papers/177418 | PubMed |
| 7 | 177866 | Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. | N Engl J Med | 1976 | https://conductscience.org/library/papers/177866 | PubMed |
| 8 | 214430 | Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. | J Biol Chem | 1978 | https://conductscience.org/library/papers/214430 | PubMed |
| 9 | 93183 | Parenteral acyclovir therapy for herpesvirus infections in man. | Lancet | 1979 | https://conductscience.org/library/papers/93183 | PubMed |
| 10 | 6245699 | Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. | Biochim Biophys Acta | 1980 | https://conductscience.org/library/papers/6245699 | PubMed |
| 11 | 6246531 | Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6246531 | PubMed |
| 12 | 6246532 | Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6246532 | PubMed |
| 13 | 6252836 | In vitro susceptibility of varicella-zoster virus to acyclovir. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252836 | PubMed |
| 14 | 7427624 | Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster. | Br Med J | 1980 | https://conductscience.org/library/papers/7427624 | PubMed |
| 15 | 6256650 | Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. | Nature | 1981 | https://conductscience.org/library/papers/6256650 | PubMed |
| 16 | 6116951 | Acyclovir in herpes zoster. | Lancet | 1981 | https://conductscience.org/library/papers/6116951 | PubMed |
| 17 | 6275127 | Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. | J Virol | 1981 | https://conductscience.org/library/papers/6275127 | PubMed |
| 18 | 6299833 | Development of sensitive and enzyme-linked immunoassays for herpesvirus antigens and some applications. | Dev Biol Stand | 1982 | https://conductscience.org/library/papers/6299833 | PubMed |
| 19 | 6300257 | Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6300257 | PubMed |
| 20 | 6312958 | Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine. | Biken J | 1983 | https://conductscience.org/library/papers/6312958 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36389670 | EBV-associated diseases: Current therapeutics and emerging technologies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389670 | PubMed |
| 33672709 | Advances and Perspectives in the Management of Varicella-Zoster Virus Infections. | Molecules | 2021 | https://conductscience.org/library/papers/33672709 | PubMed |
| 29899236 | Antiviral Drugs for EBV. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29899236 | PubMed |
| 27694307 | Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27694307 | PubMed |
| 25275644 | Current and potential treatments for ubiquitous but neglected herpesvirus infections. | Chem Rev | 2014 | https://conductscience.org/library/papers/25275644 | PubMed |
| 16284630 | Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16284630 | PubMed |
| 11353604 | Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11353604 | PubMed |
| 9835529 | The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9835529 | PubMed |
| 8392312 | Efficacy of (-)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in African green monkeys infected with simian varicella virus. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8392312 | PubMed |
| 7486922 | Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7486922 | PubMed |
| 2854453 | Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/2854453 | PubMed |
| 2540706 | Improvement of the absorption of oral (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, an anti-varicella-zoster virus drug, in rats and monkeys. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2540706 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| POLA1 | 5422 | PubTator's text mining | https://conductscience.org/library/genes/5422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2847643
GET https://conductscience.org/api/papers/v1/2847643/references?page=2